adaptbrian 6 hours ago This is crazy the science has since been debunked and the fda clears it?Someone with more understanding of how the fda process works will need to chime in, how can this happen? hajik 5 hours ago Debunking amyloid build up as the cause is different than debunking amyloid build up as any kind of correlation.
hajik 5 hours ago Debunking amyloid build up as the cause is different than debunking amyloid build up as any kind of correlation.
bartoszcki 7 hours ago "It is designed for the early detection of amyloid, a protein that can build up in the brain and is a hallmark of Alzheimer’s"Seems like they did not read the news (for a year or two) or hope their clients didn't.
hyperhello 8 hours ago I tried to read the story but the screen began to fade and become blurry and I was distracted by a request for money. So I have Alzheimer’s?
anotherhue 9 hours ago I wonder why they start at 55, early onset AD is very difficult to diagnose. hajik 2 hours ago Sounds like the choice between a separate clinical test for a rarer diagnosis, (which generally means more expenses for a smaller market) or just leaving it to doctors to do off label use.
hajik 2 hours ago Sounds like the choice between a separate clinical test for a rarer diagnosis, (which generally means more expenses for a smaller market) or just leaving it to doctors to do off label use.
This is crazy the science has since been debunked and the fda clears it?
Someone with more understanding of how the fda process works will need to chime in, how can this happen?
Debunking amyloid build up as the cause is different than debunking amyloid build up as any kind of correlation.
https://archive.ph/qE0nV
"It is designed for the early detection of amyloid, a protein that can build up in the brain and is a hallmark of Alzheimer’s"
Seems like they did not read the news (for a year or two) or hope their clients didn't.
I tried to read the story but the screen began to fade and become blurry and I was distracted by a request for money. So I have Alzheimer’s?
I wonder why they start at 55, early onset AD is very difficult to diagnose.
Sounds like the choice between a separate clinical test for a rarer diagnosis, (which generally means more expenses for a smaller market) or just leaving it to doctors to do off label use.